ENDOTHELIUM IN CARDIOVASCULAR FUNCTION

这是第四届会议的部分经费申请。 浅谈血管内皮细胞与心血管功能 美国实验学会联合会赞助 生物学-(FASE B)，从1997年6月29日至1997年7月4日，在 科罗拉多州的铜山度假村。1997年的主题 FASEB夏季会议反映了BASIC的最新发展 以及与生理和临床相关的研究 血管内皮细胞在心血管疾病中的病理生理作用 功能。这次会议的重点将放在表达上， 多种血管内皮细胞来源的生物合成、调控及作用 在调节血管方面发挥明显和决定性作用的因素 健康和疾病中的重塑、生长和血流。 参加人数限制为200名科学家，包括会议。 演讲者和讨论领导者，他们是根据 他们的专业知识和最近对这一研究领域的贡献 以及谁可能会为建立一个激励性的 和富有成效的氛围。FASE B夏季考试的典型格式 会议将与一些次要但重要的变化一起使用。 每个上午和晚上的会议将限制为4名演讲者， 允许有足够的时间进行广泛讨论的目的是， 这是FASE B夏季会议计划的目标。 这意味着演讲者总数减少了，但这一研究领域的专家 谁将不是会议发言人已被邀请参加讨论 领导人和/或出席和参加会议。海报 我们强烈鼓励并将宣传演示文稿， 表演网站可以处理200篇摘要。海报评审会 将被组织起来，以便某些选定的摘要可以 在最近的每个海报会议结束时进行了广泛的讨论 每个下午。会议形式旨在整合新的 信息，并促进对未来研究和 临床应用。

This is an application for the partial funding of the fourth conference on Endothelium and Cardiovascular Function to be held under the auspices of the Federation of American Societies for Experimental Biology - (FASEB), from June 29, 1997 to July 4, 1997 at the Copper Mountain Resort in Colorado. The theme of the 1997 FASEB Summer Conference reflects recent developments in basic and clinical research pertaining to the physiological and pathophysiological roles of the endothelium in cardiovascular function. The focus of this conference will be on the expression, biosynthesis, modulation and actions of various endothelium-derived factors that play distinct and definitive roles in modulating vascular remodeling, growth and blood flow in health and disease. Participation is limited to 200 scientists, including the session speakers and discussion leaders, who have been-selected on the basis of their expertise and recent contributions to this area of research and who will likely contribute to the establishment of a stimulating and productive atmosphere. The typical format of a FASEB Summer Conference will be used with some minor but important variations. Each morning and evening session will be limited to 4 speakers, for the purpose of allowing adequate time for extensive discussion, which is the objective of the FASEB Summer Conference program. This means fewer total speakers, but experts in this area of research who will not be session speakers have been invited to be discussion leaders and/or to attend and participate in the conference. Poster presentations are strongly encouraged and will be advertised, as the performance site can handle 200 abstracts. Poster review sessions will be organized so that certain selected abstracts can be more extensively discussed at the end of each poster session in the late afternoons. The conference format is designed to integrate new information and facilitate extensive discussion of future research and clinical applications.